Section
Deals
M&A, licensing, and major transactions shaping the industry
DealsFierceBiotech ↗
London-based Global Healthcare Opportunities and Singapore-based CBC Group announced plans to merge, creating …
DealsFierceBiotech ↗
With the ink barely dry on an antibody-drug conjugate-style deal with Regeneron, Parabilis Medicines has now t…
DealsBriefing
After a failed A-T trial and cash crunch, Quince merges with Orphai Therapeutics, keeping its Nasdaq listing a…
DealsFierceBiotech ↗
Regeneron has ponied up $125 million in cash and an equity investment in Parabilis Medicines to join forces on…
DealsEndpoints News ↗
Biopharma's deals landscape could hardly be better, as large companies take a multi-pronged approach to withst…
DealsBriefing
Taiwan’s Bora Group is buying MacroGenics’ Maryland CDMO operations, adding a 20,000‑liter biologics capacity …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.